Journal
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
Volume 56, Issue 4, Pages 785-791Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jpba.2011.07.041
Keywords
HPLC-UV; SPE; Efavirenz; Rifampicin; Desacetyl rifampicin; Plasma
Categories
Funding
- IRCSET (Irish Research Council for Science, Engineering and Technology)
Ask authors/readers for more resources
A simple and rapid isocratic, high performance liquid chromatography (HPLC) assay employing solid phase extraction (SPE) for the simultaneous determination of the anti HIV drug, efavirenz, the antituberculosis drug, rifampicin and the desacetyl metabolite of rifampicin in plasma from HIV/tuberculosis infected patients has been developed. Using a Zorbax SB-Phenyl reverse-phase analytical column with UV detection, good separation and detection of the drugs was attained within a 10 min run time. Intra- and inter-assay precision RSD values were found to be less than 15% at the concentrations examined (0.1-20 mu g/mL). The LOQ was found to be 0.1 mu g/mL for each agent and the assay was found to generate a linear response up to 20 mu g/mL. This low cost assay can accurately detect efavirenz and rifampicin concentrations within a clinically relevant concentration range using standard chromatography equipment, making it particularly applicable to resource-limited settings. (C) 2011 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available